Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06491537 · ClinicalTrials.gov registry record · NA

Time-restricted Eating for Postpartum Weight Loss

A NA study of Overweight and Obesity and Postpartum Weight Retention, sponsored by University of Alabama at Birmingham.

Recruiting
Registry status
NA
Development phase
60
Enrollment target
1
Study location

NCT06491537: Recruiting NA study of Overweight and Obesity and Postpartum Weight Retention, sponsored by University of Alabama at Birmingham.

NCT06491537 is a NA study of Overweight and Obesity and Postpartum Weight Retention that is actively recruiting participants, run by University of Alabama at Birmingham. The registered enrollment target is 60 participants, below the 228-participant average among 115 other Overweight and Obesity trials with a reported enrollment target (74% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06491537, a NA study of Overweight and Obesity and Postpartum Weight Retention, is actively recruiting participants, sponsored by University of Alabama at Birmingham.

RECRUITING
Registry status
NA
Development phase
60 participants
Enrollment target
1
Study location

Study Summary

This study is being done to assess the feasibility and acceptability of a time-restricted eating intervention among postpartum women with overweight/obesity.

Primary Outcome

Percentage of eligible subjects who agreed to participate out of those who were screened.

Interventions

  • BEHAVIORAL Control
  • BEHAVIORAL Early Time-Restricted Eating (eTRE)

Study Locations (1)

Alabama

  • University of Alabama at Birmingham - Birmingham

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2025-05-22
Est. Completion 2029-02-01
Phase NA
University of Alabama at Birmingham

1,160 total trials

What NCT06491537 shows while recruiting

NCT06491537 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 228-participant average among 115 other Overweight and Obesity trials with a reported enrollment target (74% lower).

The record links to 2 conditions, with Overweight and Obesity appearing as the primary indexed condition, and to 2 interventions - of which Control is the first listed.

NCT06491537 reports a single indexed study location in Alabama.

Frequently Asked Questions

What is clinical trial NCT06491537 about?

NCT06491537 is a clinical study titled "Time-restricted Eating for Postpartum Weight Loss". This study is being done to assess the feasibility and acceptability of a time-restricted eating intervention among postpartum women with overweight/obesity.

What is the current status of trial NCT06491537?

This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2025-05-22. Estimated completion is 2029-02-01.

What conditions does trial NCT06491537 study?

This clinical trial studies the following conditions: Overweight and Obesity, Postpartum Weight Retention.

What interventions are being tested in trial NCT06491537?

The interventions under investigation include: Control (BEHAVIORAL), Early Time-Restricted Eating (eTRE) (BEHAVIORAL).

Who is sponsoring clinical trial NCT06491537?

This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06491537 being conducted?

This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Overweight and Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06491537's enrollment target sits among peer trials

60 79th of 115 higher than 34 of 115 other Overweight and Obesity trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Overweight and Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00576069 · 60 participants

    Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma

  • NCT01297400 · 60 participants · Phase 2

    Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns

  • NCT01734122 · 60 participants

    Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor

  • NCT01804634 · 60 participants · Phase 2

    Reduced Intensity Haploidentical BMT for High Risk Solid Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06491537, the US trial registry maintained by the National Library of Medicine. NCT06491537 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.